A genotype-directed phase I–IV dose-finding study of irinotecan in combination with fluorouracil/leucovorin as first-line treatment in advanced colorectal cancer
Keyword(s):
Phase I
◽
2019 ◽
Vol 85
(1)
◽
pp. 113-119
◽
Keyword(s):
Keyword(s):
Keyword(s):
2009 ◽
Vol 64
(2)
◽
pp. 407-412
◽
Keyword(s):